Agenda


以下是ChinaBio® 创业投资论坛2012-北京日程.(更新于2012年8月28日)

ChinaBio Investor Forum 2012-Beijing - Detailed Agenda

Tuesday, September 4, 2012

17:30 - 19:30

Welcome Reception
Meet with speakers and other attendees at this informal reception

 

Day 1 - Wednesday, September 5, 2012

Time

Title/Description

Speakers

08:00 - 09:00

Registration and Refreshments

 

09:00 - 09:30

Welcome Remarks

Greg B. Scott - President & Founder, ChinaBio® LLC

Jiantao He - Vice Director, Daxing Bio-medicine Industry Park

Marko Vänskä - CEO, China-Finland Golden Bridge

09:30 - 10:00

Keynote 1: The State of China Life Science: From Local to Global

As China's life science industry continues to lead the world in growth, it is quickly evolving from a local market to having global impact. Innovation is now being created inside of China at the same time international companies are bringing innovation to China. This has stimulated VC investment, M&A and IPO activity in China, and driven partnering and corporate investment to new heights. Mr. Scott will present recent data on the industry, highlighting areas of significant opportunity in China.

Greg B. Scott - President & Founder, ChinaBio® LLC

10:00 - 10:30

Keynote 2: BioFinland Investment Opportunities

A strong combination of science and technological expertise makes Finland one of the most competitive nations in the world in biotechnology and healthcare. Finnish life science companies are now entering the Chinese market and investors are seeking leading technologies to bring to China, making a good match. Dr. Reijonen will provide insights on the biotech industry and innovation in Finland, and which technology trends Chinese investors should keep their eye on.

Kalevi Reijonen, PhD - Board Member, Finnish Biotech Association

10:30 - 11:00

Networking Break and Refreshments

 

11:00 - 12:00

Session 1: VC Funding in China: Alive and Well

While the US and Europe are facing a significant drought in funding available for life science companies, VC funding in China remains alive and well. Many international as well as domestic investment firms are seeking mid- and late-stage investments as well as early stage companies offering novel technologies addressing significant markets. Hear from a group of seasoned VCs managing major funds focused on the China life science industry.

Moderator:
Marc A. Schueler, MD, PhD, MBA - Senior Advisor, CW Downer

Panelists:
Min Cui, PhD - Managing Director, Decheng Capital

Karen Liu, PhD, EMBA - Partner, Kaiwu Capital

Yi Shi, PhD, MBA - Managing Director, Lilly Asian Ventures

Xiangyu Ouyang, EMBA - Managing Director, Legend Capital

Jonathan Wang, PhD, MBA - Senior Managing Director, OrbiMed

12:00 - 13:30

Luncheon

 

13:30 - 15:00

Company Presentations

 

15:00 - 17:00

VC Breakout Meetings 

 

17:00 - 18:30

Beijing Daxing Life Science Park Tour
Daxing is a prime location for life science companies in China, offering a variety of incentives and support services.

 

18:30 - 20:30

Gala Banquet
Join us at the beautiful Roaring Dragon Pavilion for a dinner fit for the royal family of the Qing Dynasty.

 

Day 2 - Thursday, September 6, 2012

Time

Title/Description

Speakers

08:30 - 09:30

Registration and Refreshments

 

09:30 - 10:30

Session 2: Alternative Funding: Corporate Partnering

Some attractive alternatives to VC money include government and corporate funding. Corporate partnering and investment are increasing rapidly in China, with more deals done in 2011 than ever before. Especially in the pharmaceutical industry, Chinese companies are seeking to build novel product portfolios through in-licensing, co-development, strategic partnerships and equity investments. Learn what some of China's most successful companies are looking for in partnerships.

Moderator:
Sherry Yin - Partner, Morrison & Foerster LLP

Panelists:
Sammy Jiang, MBA - Associate President, Luye Pharma Group Ltd.

Larry Liu - Director, Business Development Department, Beijing Hanmi pharmaceutical

Mike Liu, PhD, MBA - Head of Global Business Development, Jiangsu Hengrui Medicine Co., Ltd.

10:30 - 11:00

Networking Break and Refreshments

 

11:00 - 12:00

Session 3: How to Launch a Company in China

There are many factors to be considered when establishing a successful company in China: corporate structure, location, intellectual property, government relationships, VC funding, and more. This session will guide entrepreneurs in the best way to leverage the many benefits China can offer: funding, government incentives, talent pool, etc.

Greg B. Scott - President & Founder, ChinaBio® LLC

12:00 - 13:30

Luncheon

 

13:30 - 15:00

Company Presentations

 

15:00 - 16:00

VC Breakout Meetings

 

16:00 - 16:30

Raffle Drawings - Win valuable prizes
(Must be present to win)

 

16:30 - 17:00

Award Ceremony / Closing Remarks

 

17:00 - 18:00

Closing Reception

 

 

主办方

承办方

赞助商 & 合作伙伴

金牌赞助商
 
官方合作伙伴
 
VC合作伙伴
 
支持伙伴
 
媒体伙伴